|
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Jan. 30, 2017) - VANC Pharmaceuticals Inc. ("VANC" or the "Company") (TSX VENTURE:VANC) (OTCQB:NUVPD), a pharmaceutical company focused on the Canadian generic drug and over-the-counter (the "OTC") markets, is pleased to announce a non-brokered private placement of up to 5,416,666 units of the Company at a price of $0.24 per unit (the "Units") for gross proceeds of up to $1,300,000 (the "Offering"). |
